Explore evidence

Gold tier: mechanically validated evidence, with its primary source.

1,197 evidence items · page 36 / 48

96.1 %To detect SCD carrier, SickleScan® had a sensitivity of 96.10% (95% CI: 94.75–97.45).

Malisickle cell disease carrierobserved 2021HAL · Unilimdocument of 103 observations

3,259 specimensA total of 3,259 sandflies were collected in the ZCL foci of Bandiagara area, Mali.

Malizoonotic cutaneous leishmaniasispublished 2012PloS oneeurope_pmcdocument of 3 observations

104 casesThe age group [0–11] months accounted for 104 severe malaria cases out of a total of 2,310 severe cases, representing a severity proportion of 0.045.

MalipaludismeHAL · Unilimdocument of 80 observations

4.2 %Clinical malaria prevalence was 4.2% in 2012 among children in the health district of Koutiala, Mali.

Malipaludismeobserved 2012published 2020International journal of environmental research and public healtheurope_pmcdocument of 7 observationsDOI 10.3390/ijerph17186639

563.07 pg/mlLe niveau moyen de sRAGE était de 563,07 pg/ml chez les Fulani.

Malipaludismeobserved 2017HAL · Unilimdocument of 31 observations

3 monthsThe duration of the rainy season is consistent with the duration of the high transmission period, varying from 3 months (north) to 5 months (south) according to the analysis of rainfall and malaria data.

MalipaludismeHAL · Unilimdocument of 95 observations

21.79 %Among 3648 newborns diagnosed by HPLC in Mali from April 2021 to August 2021, 21.79% were sickle cell disease carriers.

Malidrépanocytoseobserved April 2021 to August 2021HAL · Unilimdocument of 103 observations

252 per_1000Dans le bras intervention, les agents de santé communautaires ont atteint 1 539 patients et 388 tests antigéniques rapides pour la COVID-19 ont été réalisés, soit 252 tests antigéniques rapides pour 1 000 patients.

MaliCOVID-19HAL · Unilimdocument of 36 observations

21 %A significant proportion of participants believed that COVID-19 was caused by witchcraft (21%).

MaliCOVID-19HAL · Unilimdocument of 88 observations

14 %In Mali, glucose-6-phosphate dehydrogenase (G6PD (A−)) deficiency is found at an overall frequency of 14%.

Maliglucose-6-phosphate dehydrogenase deficiencypublished 2011American Journal of HematologyOpenAlexdocument of 9 observationsDOI 10.1002/ajh.22093

244,000,000 casesIn 2021, there were an estimated 244 million cases of malaria worldwide.

Malipaludismeobserved 2021HAL · Unilimdocument of 111 observations

258 casesOf the 1,389 tested by qPCR RDTs, 258 (18.6%) were positive for Plasmodium spp.

Malipaludismepublished 2023Performance of Rapid Diagnostic Tests for Malaria Diagnosis in Malieurope_pmcdocument of 3 observationsDOI 10.20944/preprints202311.1579.v1

3 casesThree cases of cryptosporidiosis and one case of isosporosis were observed in the leprosy group versus none in the control group.

MaliCryptosporidiosis · isosporosis · leprosyobserved March 1999 to February 2000published 2002Medecine tropicale : revue du Corps de sante colonialeurope_pmcdocument of 7 observations

21.1 %Plasmodium vivax prevalence reached 21.1% in the north of Mali.

Malipaludismepublished 2024International journal of environmental research and public healtheurope_pmcdocument of 5 observations

Higher antibody levels at the time of hospital admission were associated with shorter treatment durations for COVID-19.

MaliCOVID-19HAL · Unilimdocument of 67 observations

94.5 %The highest intermittent preventive treatment in pregnancy (IPTp) coverage rate (94.5%) was observed in the health district of Kangaba (Koulikoro region in the south) in the year 2021–2022.

Malipaludismeobserved 2021–2022HAL · Unilimdocument of 111 observations

18.35 nMQuinine was significantly more potent against Plasmodium malariae than Plasmodium falciparum in Mali, with IC50 values of 18.35 nM versus 26.84 nM.

Malipaludismepublished 2025Microbiology spectrumeurope_pmcdocument of 5 observations

2.08 R0The estimated basic reproduction number (R0) of COVID-19 was 2.08.

MaliCOVID-19HAL · Unilimdocument of 88 observations

31.9 %Among 266 COVID-19 samples, 85 (31.9%) recognized the receptor-binding motif (RBM) antigen.

MaliCOVID-19HAL · Unilimdocument of 67 observations

2 %The prevalence of HbSS in Mali is around 2%.

MalidrépanocytoseHAL · Unilimdocument of 103 observations

98.9 %The adequate clinical and parasite response rate corrected by polymerase chain reaction (ACPRc) among non-AL treatment arms at Mali study sites was 98.9%.

Malipaludismepublished 2021Malaria journaleurope_pmcdocument of 2 observationsDOI 10.1186/s12936-021-03890-0

74 %In Kilifi County, Kenya, 74% of children in the case group had the G6PD normal genotype.

Malidéficit en G6PDpublished 2015The Lancet. Haematologyeurope_pmcdocument of 11 observationsDOI 10.1016/s2352-3026(15)00152-0

912 childrenOverall 912 children aged between six to 59 months with uncomplicated P. falciparum malaria were recruited in the trial in Mali.

Malipaludismepublished 2015Malaria journaleurope_pmcdocument of 7 observations

8 %HIV-attributed mortality among infants and children was 8% in Mali (13 [8%] of 168).

MaliVIH/sidaobserved Dec 3, 2016 to Dec 31, 2024published 2026The lancet. HIVPubMeddocument of 23 observations

11.29 %Au Mali, la proportion de faible poids de naissance est passée de 11,29 % à 7,6 % entre 2020 et 2023.

Malifaible poids de naissanceobserved 2020 à 2023HAL · Unilimdocument of 302 observations

Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.